thymidine has been researched along with sulindac sulfone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruce, JN; Delohery, TM; Fetter, J; Gundersen, GG; Palazzo, AF; Pamukcu, R; Sperl, G; Thompson, WJ; Warburton, PE; Weinstein, IB; Whitehead, C; Xiao, D; Yoon, JT | 1 |
1 other study(ies) available for thymidine and sulindac sulfone
| Article | Year |
|---|---|
CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle Proteins; Cell Division; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 5; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Glioma; Humans; Immunoenzyme Techniques; In Vitro Techniques; Interphase; Kinesins; Mice; Microtubules; Phosphoproteins; Phosphoric Diester Hydrolases; Rats; Spindle Apparatus; Sulindac; Thymidine | 2002 |